Trials / Completed
CompletedNCT00705081
Evaluation of the LDL-C Lowering Effects of Ezetimibe Achieved in Co-administration Therapy With Statins in an Indonesian Population (Study P04276)(COMPLETED)
Observational Study Evaluating the LDL-C Lowering Effects of Ezetimibe With a Statin as Prescribed in Daily Routine Practice in an Indonesian Population
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 453 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of the low-density lipoprotein-cholesterol (LDL-C) lowering in an Indonesian population treated with ezetimibe co-administered with a statin in routine daily practice. In addition, the study will investigate whether and to what extent the target levels set by the participating doctors are achieved by the co-administration therapy.
Detailed description
Sampling method: invitation to the physician's patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ezetimibe | 10 mg once daily |
| DRUG | statin |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2008-06-25
- Last updated
- 2022-02-09
- Results posted
- 2009-08-03
Source: ClinicalTrials.gov record NCT00705081. Inclusion in this directory is not an endorsement.